Remove 2010 Remove Cannabis Remove Research and Development Remove Safety
article thumbnail

Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief Research Officer

Cannabis Law Report

Nutt Will Drive Progression of a Pipeline of New Psychedelic Medicines, Helping to Define a Clear Development Pathway to Treat Addiction Through Psychedelic Medicines. David Nutt, has joined its executive team as Chief Research Officer. Toronto, Ontario–(Newsfile Corp. June 24, 2021) – Awakn Life Sciences Corp.

article thumbnail

Will Newly Developing Drug Breathalyzers Replace Other Forms of Testing?

Cannabis Law Report

PUBLISHER: CANNABIS LAW REPORT. She was the Presiding Judge 2009 and 2010 and the co-founder of the Denver County Court Sobriety Court. There are newly developing alternative testing devises that use oral fluid and drug breathalyzers. Several factors are contributing to the development and use of these alternatives.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

California: Department of Cannabis Control Names Leadership Team

Cannabis Law Report

Here’s who’s been appointed and their short bios… The Department of Cannabis Control (DCC) was established Monday, July 12. The creation of this standalone cannabis department is part of a larger effort to improve access to licensure, simplify regulatory oversight and support California businesses. Biographies.

article thumbnail

The Effort to Decriminalize Psilocybin in California is Underway

Canna Law Blog

Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver , and Santa Cruz have decriminalized psilocybin to varying degrees. Magic Mushrooms are much safer than caffeine, nicotine, and alcohol.

article thumbnail

Europe’s Leading Psychedelic Conference Returns to Amsterdam In September

Cannabis Law Report

The OPEN Foundation invites you to the Interdisciplinary Conference on Psychedelic Research this September, featuring the world’s best experts on psychedelic science and therapy. Research participant perspectives are featured prominently, and experts will discuss issues around ethics, investment, and the hype surrounding psychedelics.

article thumbnail

How Good Is Cannabis for Multiple Sclerosis (MS)?

Greencamp

Here’s whether cannabis can help. For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. Although they still can’t say for sure, scientists think that certain genetic and environmental factors play a role in developing MS. What is multiple sclerosis?

article thumbnail

Cannabis – The study that blew my mind

Cannabis Law Report

I was a young cannabis research student on my first trip overseas to an international research conference. Events like these afford us a glimpse into the future of research and medicine in this field. None of the patients developed acute GVHD while consuming CBD (ie, before day 30).